respiporc flupan h1n1
ceva santé animale - influenza a virus/human strain: a/jena/vi5258/2009 (h1n1)pdm09, inactivated - imunološke, inaktivirane virusne vakcine za svinje, virus influence gripe - svinje - aktivna imunizacija svinja od dobi od 8 tjedana nadalje protiv pandemijskog virusa influence h1n1 svinjske gripe kako bi se smanjio virusni opterećenje pluća i virusni izlučivanje. the vaccine can be used during pregnancy up to three weeks before expected farrowing and during lactation lactation.
flucelvax tetra
seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - gripa, ljudska - virus gripe, инактивированная, split ili površinski antigen - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra treba primjenjivati u skladu sa službenim preporukama.
carboplasin 450 mg/45 ml koncentrat za rastvor za infuziju
pliva d.o.o.sarajevo - karboplatin - koncentrat za rastvor za infuziju - 450 mg/45 ml - 45 ml koncentrata za rastvor za infuziju sadrži: 450 mg karboplatina
carboplasin 150 mg/15 ml koncentrat za rastvor za infuziju
pliva d.o.o.sarajevo - karboplatin - koncentrat za rastvor za infuziju - 150 mg/15 ml - 15 ml koncentrata za rastvor za infuziju sadrži: 150 mg karboplatina
carboplasin 50 mg/5 ml koncentrat za rastvor za infuziju
pliva d.o.o.sarajevo - karboplatin - koncentrat za rastvor za infuziju - 50 mg/5 ml - 5 ml koncentrata za rastvor za infuziju sadrži: 50 mg karboplatina
fluad tetra
seqirus netherlands b.v. - a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) / a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238) / b/phuket/3073/2013-like strain (b/phuket/3073/2013, bvr-1b) / influenza virus b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - gripa, ljudska - cjepiva - prevencija gripe kod osoba starije dobi (65 godina i stariji). fluad tetra treba primjenjivati u skladu sa službenim preporukama.
efluelda, suspenzija za injekciju u napunjenoj štrcaljki, četverovalentno cjepivo protiv influence (fragmentirani virion, inaktivirano), 60 mikrograma ha/soju
sanofi pasteur, 14 espace henry vallee, lyon, francuska - soj virusa influence (inaktivirani, fragmentirani) tip a (h1n1) soj virusa influence (inaktivirani, fragmentirani) tip a (h3n2) soj virusa influence (inaktivirani, fragmentirani) tip b - suspenzija za injekciju u napunjenoj štrcaljki - 1 doza = 0,7 ml - urbroj: 1 doza (0,7 ml) sadrži 60 mikrograma hemaglutinina po soju virusa influence (inaktivirani, fragmentirani) za sezonu aktualnih sojeva tip a (h1n1), tip a (h3n2) i dva soja tipa b
remsima 100 mg/1 bočica prašak za koncentrat za otopinu za infuziju
oktal pharma d.o.o. sarajevo - infliksimab - prašak za koncentrat za otopinu za infuziju - 100 mg/1 bočica - 1 bočica praška za koncentrat za otopinu za infuziju sadrži: 100 mg infliksimaba
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningitis, meningokokal - cjepiva - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.
nobivac dp plus
intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - imunomodulatori za псовые - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.